| 1 |
34952465 | Lenalidomide attenuates post-inflammation pulmonary fibrosis through blocking NF-κB signaling pathway. | 2022 Feb |
1 |
| 2 |
32321757 | IKZF3/Aiolos Is Associated with but Not Sufficient for the Expression of IL-10 by CD4+ T Cells. | 2020 Jun 1 |
1 |
| 3 |
32761232 | Immunomodulatory drugs suppress Th1-inducing ability of dendritic cells but enhance Th2-mediated allergic responses. | 2020 Aug 11 |
1 |
| 4 |
31141702 | Anti-inflammatory modulation of human myeloid-derived dendritic cell subsets by lenalidomide. | 2019 Jul |
1 |
| 5 |
29986852 | Phase 1 investigation of lenalidomide/rituximab plus outcomes of lenalidomide maintenance in relapsed CNS lymphoma. | 2018 Jul 10 |
1 |
| 6 |
29379494 | The CXCR4-STAT3-IL-10 Pathway Controls the Immunoregulatory Function of Chronic Lymphocytic Leukemia and Is Modulated by Lenalidomide. | 2017 |
5 |
| 7 |
25398834 | Lenalidomide interferes with tumor-promoting properties of nurse-like cells in chronic lymphocytic leukemia. | 2015 Feb |
1 |
| 8 |
22733396 | Lenalidomide enhances anti-myeloma cellular immunity. | 2013 Jan |
1 |
| 9 |
24482747 | Trial Watch: Lenalidomide-based immunochemotherapy. | 2013 Nov 1 |
1 |
| 10 |
21748755 | Lenalidomide modulates IL-8 and anti-prostate antibody levels in men with biochemically recurrent prostate cancer. | 2012 Apr |
1 |